David Rizzo

1.7k total citations · 1 hit paper
19 papers, 1.1k citations indexed

About

David Rizzo is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, David Rizzo has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 11 papers in Pathology and Forensic Medicine and 6 papers in Immunology. Recurrent topics in David Rizzo's work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (11 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). David Rizzo is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (11 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). David Rizzo collaborates with scholars based in France, United States and Lebanon. David Rizzo's co-authors include Carolyn Hughes, James F. Luther, Andrea L. Confer, Dorothy Sit, Heather Eng, Stephen R. Wisniewski, Katherine L. Wisner, Barbara H. Hanusa, Eydie L. Moses‐Kolko and Jean Feuillard and has published in prestigious journals such as American Journal of Psychiatry, Frontiers in Immunology and PLoS Computational Biology.

In The Last Decade

David Rizzo

19 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Onset Timing, Thoughts of Self-harm, and Diagnoses in Postpartum Women With Screen-Positive Depression Findings

2013 758 citations Katherine L. Wisner, Dorothy Sit et al. JAMA Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Rizzo France	10	800	366	272	193	147	19	1.1k
Christian Créveuil France	18	428 0.5×	194 0.5×	253 0.9×	353 1.8×	32 0.2×	57	1.3k
Punit D. Wadhwa United States	9	204 0.3×	97 0.3×	49 0.2×	164 0.8×	191 1.3×	11	683
Florian Faschingbauer Germany	20	411 0.5×	139 0.4×	565 2.1×	537 2.8×	14 0.1×	92	1.4k
Roberta Venturella Italy	27	1.0k 1.3×	172 0.5×	1.1k 4.0×	635 3.3×	53 0.4×	117	2.6k
Setsuko Goto Japan	20	568 0.7×	247 0.7×	182 0.7×	227 1.2×	12 0.1×	61	1.0k
Kazutomo Ohashi Japan	20	477 0.6×	173 0.5×	175 0.6×	180 0.9×	19 0.1×	71	1.1k
Mauro Cozzolino Spain	24	793 1.0×	146 0.4×	587 2.2×	438 2.3×	27 0.2×	104	1.6k
Cesare Battaglia Italy	31	1.1k 1.3×	90 0.2×	350 1.3×	249 1.3×	75 0.5×	120	2.5k
Christine Derzko Canada	15	193 0.2×	100 0.3×	103 0.4×	82 0.4×	53 0.4×	30	1.2k
Marianne Wulff Sweden	20	1.1k 1.3×	444 1.2×	581 2.1×	421 2.2×	8 0.1×	44	1.8k

Countries citing papers authored by David Rizzo

Since Specialization

Citations

This map shows the geographic impact of David Rizzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rizzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rizzo more than expected).

Fields of papers citing papers by David Rizzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Rizzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rizzo. The network helps show where David Rizzo may publish in the future.

Co-authorship network of co-authors of David Rizzo

This figure shows the co-authorship network connecting the top 25 collaborators of David Rizzo. A scholar is included among the top collaborators of David Rizzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Rizzo. David Rizzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Aoufouchi, Saïd, et al.. (2024). Increased c-MYC Expression Associated with Active IGH Locus Rearrangement: An Emerging Role for c-MYC in Chronic Lymphocytic Leukemia. Cancers. 16(22). 3749–3749. 1 indexed citations

Aoufouchi, Saïd, David Rizzo, Nathalie Faumont, et al.. (2023). IGH 3’RR recombination uncovers a non-germinal center imprint and c-MYC-dependent IGH rearrangement in unmutated chronic lymphocytic leukemia. Haematologica. 109(2). 466–478. 2 indexed citations

Mumford, Elizabeth, A. J. C. Cook, Gail R. Hansen, et al.. (2023). Evolution and expansion of the One Health approach to promote sustainable and resilient health and well-being: A call to action. Frontiers in Public Health. 10. 1056459–1056459. 34 indexed citations

Rizzo, David, Delphine Rossille, Robin Jeannet, et al.. (2023). Demultiplexing Ig repertoires by parallel mRNA/DNA sequencing shows major differential alterations in severe COVID-19. iScience. 26(3). 106260–106260. 1 indexed citations

Bourthoumieu, Sylvie, David Rizzo, Pascal Turlure, et al.. (2023). Hereditary predisposition to malignant myeloid hemopathies: Caution in use of saliva and guideline based on our experience. Frontiers in Oncology. 13. 1120829–1120829. 1 indexed citations

Gachard, Nathalie, Stéphanie Poulain, David Rizzo, et al.. (2021). Continuous MYD88 Activation Is Associated With Expansion and Then Transformation of IgM Differentiating Plasma Cells. Frontiers in Immunology. 12. 641692–641692. 8 indexed citations

Leymarie, Vincent, Estelle Guérin, Franck Trimoreau, et al.. (2021). Flow cytometry detection of CD138 expression continuum between monotypic B and plasma cells is associated with both high IgM peak levels and MYD88 mutation and contributes to diagnosis of Waldenström macroglobulinemia. Cytometry Part B Clinical Cytometry. 102(1). 62–69. 2 indexed citations

Rizzo, David, Corinne Magdelaine, Sylvie Bourthoumieu, et al.. (2020). CovCopCan: An efficient tool to detect Copy Number Variation from amplicon sequencing data in inherited diseases and cancer. PLoS Computational Biology. 16(2). e1007503–e1007503. 20 indexed citations

Pastoret, Cédric, et al.. (2020). A reduced panel of eight genes (ATM, SF3B1, NOTCH1, BIRC3, XPO1, MYD88, TNFAIP3, and TP53) as an estimator of the tumor mutational burden in chronic lymphocytic leukemia. International Journal of Laboratory Hematology. 43(4). 683–692. 3 indexed citations

10.

Togami, Eri, Jennifer L. Gardy, Gail R. Hansen, et al.. (2018). Core Competencies in One Health Education: What Are We Missing?. NAM Perspectives. 8(6). 26 indexed citations

11.

Duchesne, Mathilde, Thierry Maisonobe, Nathalie Gachard, et al.. (2018). Pathology of Nerve Biopsy and Diagnostic Yield of PCR-Based Clonality Testing in Neurolymphomatosis. Journal of Neuropathology & Experimental Neurology. 77(9). 769–781. 15 indexed citations

12.

Lia, Anne‐Sophie, François Boyer, Arnaud Jaccard, et al.. (2018). Normal serum protein electrophoresis and mutated IGHV genes detect very slowly evolving chronic lymphocytic leukemia patients. Cancer Medicine. 7(6). 2621–2628. 6 indexed citations

13.

Rizzo, David, Pierre‐Julien Viailly, Sylvain Mareschal, et al.. (2016). Oncogenic events rather than antigen selection pressure may be the main driving forces for relapse in diffuse large B‐cell lymphomas. American Journal of Hematology. 92(1). 68–76. 9 indexed citations

14.

Rizzo, David, Franck Trimoreau, Jean‐Baptiste Woillard, et al.. (2014). IgM peak independently predicts treatment-free survival in chronic lymphocytic leukemia and correlates with accumulation of adverse oncogenetic events. Leukemia. 29(2). 337–345. 15 indexed citations

15.

Wisner, Katherine L., Debra L. Bogen, Dorothy Sit, et al.. (2013). Does Fetal Exposure to SSRIs or Maternal Depression Impact Infant Growth?. American Journal of Psychiatry. 170(5). 485–493. 50 indexed citations

16.

Wisner, Katherine L., Dorothy Sit, David Rizzo, et al.. (2013). Onset Timing, Thoughts of Self-harm, and Diagnoses in Postpartum Women With Screen-Positive Depression Findings. JAMA Psychiatry. 70(5). 490–490. 758 indexed citations breakdown →

17.

Rizzo, David, Nathalie Gachard, Jean‐Luc Faucher, et al.. (2013). Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment‐free survival. American Journal of Hematology. 88(9). 747–753. 15 indexed citations

18.

Rizzo, David, Ibtissam Youlyouz‐Marfak, Estelle Guérin, et al.. (2012). T/B ratio does not reflect levels of ZAP70 expression in clonal CLL B‐cells due to ZAP70 overexpression in patient T‐cells. Cytometry Part B Clinical Cytometry. 84B(2). 125–132. 3 indexed citations

19.

Gachard, Nathalie, Marie Parrens, Isabelle Soubeyran, et al.. (2012). IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. Leukemia. 27(1). 183–189. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact